Header Logo

Connection

Dongsheng Guo to Cell Line

This is a "connection" page, showing publications Dongsheng Guo has written about Cell Line.
Connection Strength

0.848
  1. Guo D, Daman K, Chen JJ, Shi MJ, Yan J, Matijasevic Z, Rickard AM, Bennett MH, Kiselyov A, Zhou H, Bang AG, Wagner KR, Maehr R, King OD, Hayward LJ, Emerson CP. iMyoblasts for ex vivo and in vivo investigations of human myogenesis and disease modeling. Elife. 2022 01 25; 11.
    View in: PubMed
    Score: 0.140
  2. Guo D, Wu F, Liu H, Gao G, Kou S, Yang F, Abbas N, Zhou T, Cai X, Zhang H, Qin D, Li J, Xu K, Li YX. Generation of non-integrated induced pluripotent stem cells from a 59-year-old female with multiple endocrine neoplasia type 1 syndrome. Stem Cell Res. 2017 01; 18:64-66.
    View in: PubMed
    Score: 0.098
  3. Guo D, Liu H, Gao G, Liu Y, Zhuang Y, Yang F, Wang K, Zhou T, Qin D, Hong L, Li J, Xu K, Li YX. Creating a patient carried Men1 gene point mutation on wild type iPSCs locus mediated by CRISPR/Cas9 and ssODN. Stem Cell Res. 2017 01; 18:67-69.
    View in: PubMed
    Score: 0.098
  4. Guo D, Wu F, Liu H, Gao G, Kou S, Yang F, Abbas N, Zhou T, Cai X, Zhang H, Qin D, Li J, Xu K, Li YX. Generation of non-integrated induced pluripotent stem cells from a 23-year-old male with multiple endocrine neoplasia type 1 syndrome. Stem Cell Res. 2017 01; 18:70-72.
    View in: PubMed
    Score: 0.098
  5. Guo D, Liu H, Gao G, Ruzi A, Wang K, Wu H, Lai K, Liu Y, Yang F, Lai L, Li YX. Generation of an Abcc8 homozygous mutation human embryonic stem cell line using CRISPR/Cas9. Stem Cell Res. 2016 11; 17(3):640-642.
    View in: PubMed
    Score: 0.097
  6. Guo D, Liu H, Gao G, Ruzi A, Wang K, Wu H, Lai K, Liu Y, Yang F, Lai L, Li YX. Generation of an Abcc8 heterozygous mutation human embryonic stem cell line using CRISPR/Cas9. Stem Cell Res. 2016 11; 17(3):670-672.
    View in: PubMed
    Score: 0.097
  7. Ho JC, Zhou T, Lai WH, Huang Y, Chan YC, Li X, Wong NL, Li Y, Au KW, Guo D, Xu J, Siu CW, Pei D, Tse HF, Esteban MA. Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A/C. Aging (Albany NY). 2011 Apr; 3(4):380-90.
    View in: PubMed
    Score: 0.066
  8. Liu Y, Wu F, Liu D, Wei R, Abbas N, Xia J, Li D, Wang H, Zhuang Y, Guo D, Chen Y, Wu Y, Ke X, Tao J, Yang F, Lai K, Shu X, Li YX. Generation of WAe001-A-15, a human embryonic stem cell line with miR-122 doxycycline-inducible expression. Stem Cell Res. 2018 05; 29:84-87.
    View in: PubMed
    Score: 0.027
  9. Xu G, Guo D, Wu F, Abbas N, Lai K, Yuan F, You K, Liu Y, Zhuang Y, Wu Y, Xu Y, Chen Y, Yang F, Pan T, Li YX. Generation of a GDE heterozygous mutation human embryonic stem cell line WAe001-A-14 by CRISPR/Cas9 editing. Stem Cell Res. 2018 03; 27:38-41.
    View in: PubMed
    Score: 0.026
  10. Yuan F, Guo D, Liu Y, Xu Y, Gao G, Wu Y, Yang F, Ke X, Lai K, Wei H, Li YX. Generation of an ASS1 heterozygous knockout human embryonic stem cell line, WAe001-A-13, using CRISPR/Cas9. Stem Cell Res. 2018 01; 26:67-71.
    View in: PubMed
    Score: 0.026
  11. Yuan F, Guo D, Gao G, Liu Y, Xu Y, Wu Y, Yang F, Ke X, Lai K, Hong L, Li YX. Generation of a KCNJ11 homozygous knockout human embryonic stem cell line WAe001-A-12 using CRISPR/Cas9. Stem Cell Res. 2017 10; 24:89-93.
    View in: PubMed
    Score: 0.026
  12. Liu Y, Wu F, Zhuang Y, Guo D, Abbas N, Wei R, Wang K, Chen Y, Tao J, Wu Y, Yuan F, Pan T, Yang F, Lai K, Lai L, Li YX. Generation of three miR-122 knockout lines from a human embryonic stem cell line. Stem Cell Res. 2017 10; 24:164-168.
    View in: PubMed
    Score: 0.025
  13. Xu Y, Wu Y, Guo D, Gao G, Lai K, Yang F, Wang K, Wu H, Lai L, Li J, Xu K, Li YX. Generation of an ASGR1 homozygous mutant human embryonic stem cell line WAe001-A-6 using CRISPR/Cas9. Stem Cell Res. 2017 07; 22:29-32.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.